{
    "2018-04-11": [
        [
            {
                "time": "",
                "original_text": "[看好评级] 生物制品行业2018年2季度投资策略报告：看好创新药及细分领域龙头企业的发展",
                "features": {
                    "keywords": [
                        "生物制品",
                        "创新药",
                        "细分领域",
                        "龙头企业",
                        "发展"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物制品"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "[增持评级] 医药板块2018年一季报业绩前瞻：高景气细分领域延续良好增长",
                "features": {
                    "keywords": [
                        "医药板块",
                        "一季报",
                        "高景气",
                        "细分领域",
                        "良好增长"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}